Form D · Other

Colossal Biosciences Inc.

Austin, TX · CIK 0001964433

Offering snapshot reported Jul 23, 2024 · SEC filing

Reported sold
$163M
Offering amount: $174M
Investors reported
27
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 27, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$81.3M$163MFeb 10, 2023: $150,000,000.00Feb 10, 2023Jul 23, 2024: $162,599,950.00Jul 23, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$150,000,000 → $162,599,950
  • Reported investors15 → 27

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 23, 2024Amendment$162,599,950$12,599,950vs Feb 10, 202327SEC filing
Feb 10, 2023Initial$150,000,000No comparison15SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-473211

Source: Form D, filed Jul 23, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Brian Beard Director, Executive
Tom Chi Director
Benjamin Lamm Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
1401 Lavaca Street Unit #155
Austin, TX, 78701